Product Review: Naltrexone/Bupropion (Contrave®) for the Treatment of Obesity

In this review:

This article provides an overview of important pharmacological, dosage and administration, and clinical efficacy and tolerability properties and features of naltrexone/bupropion (Contrave® 8/90) in the treatment of adults who have overweight or obesity. This review is sponsored by an educational grant from Radiant New Zealand.

Download PDF Subscribe